Abiopharma

Pierre & Vacances-Center Parcs : RESULTATS SEMESTRIELS 2025/2026 (1er octobre 2025 - 31 mars 2026)

Holding(s) in Company

Pierre & Vacances-Center Parcs: First-Half 2025/2026 Results (1 October 2025 - 31 March 2026)

Notice regarding the examination of the possibility of issuing additional Tier 1 deferred debentures - update regarding the institutional auction to be held on 28.5.26

Presentation to the capital market – Q1 2026

Register of shareholders, changes and share capital status – exercise of employee warrants

Two addendums were signed to the lease agreements in the Ampha TLV property with Maccabi Healthcare Services and Assuta, details

Change in holdings of interested parties/officers - Krakow Shlomo, Bozaglo Limor

Presentation to the capital market – Q1 2026

Clinical trial NCT07218926: enrollment: not set → 450 participants.